Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF, a European Multi-center, Observational, Prospective, Single Arm and Open Label Study.

NCT03317821 is registered in ClinicalTrials.gov with Microvention-Terumo, Inc. as lead sponsor.

NCT NCT03317821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03317821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF, a European Multi-center, Observational, Prospective, Single Arm and Open Label Study.
Lead sponsor
Microvention-Terumo, Inc.
Phase
Observational
Overall status
Completed
Start date
September 18, 2017
Completion date
March 11, 2020
Enrollment
70 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

dural arteriovenous fistula